Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Study To Understand Efficacy And Safety Of Investigational Agent (PF-04937319) Compared To Approved Agent (Glimepiride) In Patients With Diabetes On Metformin

ClinicalTrials.gov ID: NCT01517373

Public ClinicalTrials.gov record NCT01517373. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 10, 2026, 8:15 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Double-blinded, Placebo-controlled, Dose-ranging, Parallel Group Study To Evaluate Safety And Efficacy Of Pf-04937319 And Glimepiride In Adult Patients With Type 2 Diabetes Mellitus Inadequately Controlled On Metformin

Study identification

NCT ID
NCT01517373
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Pfizer
Industry
Enrollment
304 participants

Conditions and interventions

Interventions

  • Glimepiride Drug
  • PF-04937319 10 mg Drug
  • PF-04937319 100 mg Drug
  • PF-04937319 50 mg Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2012
Primary completion
Dec 31, 2012
Completion
Dec 31, 2012
Last update posted
Jan 30, 2017

2012 – 2013

United States locations

U.S. sites
23
U.S. states
11
U.S. cities
20
Facility City State ZIP Site status
Sierra Clinical Research Roseville California 95661
California Research Foundation San Diego California 92103
Diablo Clinical Research, Inc. Walnut Creek California 94598
Meridien Research Bradenton Florida 34208
South Broward Research, LLC Pembroke Pines Florida 33027
East-West Medical Research Institute Honolulu Hawaii 96814
Clinical Research Center of Cape Cod, Inc. Hyannis Massachusetts 02601
Diabetes & Endocrinology Consultants, PC Morehead City North Carolina 28557
Sterling Research Group, Ltd. Cincinnati Ohio 45246
Community Research Cincinnati Ohio 45255
Coastal Carolina Research Center Mt. Pleasant South Carolina 29464
Holston Medical Group Bristol Tennessee 37620
Chattanooga Medical Research, LLC Chattanooga Tennessee 37404
Diagnostic Center Chattanooga Tennessee 37404
University Diabetes and Endocrine Consultants Chattanooga Tennessee 37411
Clinical Research Associates, Inc. Nashville Tennessee 37203
Bristol Clinical Research, LLC Austin Texas 78728
DiscoveResearch, Inc. Bryan Texas 77802
Dallas Diabetes and Endocrine Center Dallas Texas 75230
Clinical Trials of Texas, Inc. San Antonio Texas 78229
National Clinical Research - Norfolk, Inc. Norfolk Virginia 23502
National Clinical Research - Richmond, Inc. Richmond Virginia 23294
Aurora Advanced Healthcare, Inc. Milwaukee Wisconsin 53209

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 30 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01517373, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 30, 2017 · Synced May 10, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01517373 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →